Tourette's Disorder Clinical Trial
Official title:
Creating a Computerized Self-administered Version of Comprehensive Behavioral Intervention for Tics
Verified date | December 2017 |
Source | University of Utah |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Tic Disorders (including Tourette Disorder) are relatively common in school-age children and for some children can lead to significant psychosocial and physical impairment and diminished quality of life. Non-pharmacological treatments have been shown to be effective for reducing tics in some children. These treatment options are desired by parents, but are not widely available. The investigators recently developed an online, computerized, self-administered version of CBIT called TicHelper.com. The current study will test the efficacy of TicHelper.com in a randomized clinical trial.
Status | Completed |
Enrollment | 55 |
Est. completion date | August 31, 2017 |
Est. primary completion date | June 1, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 8 Years to 18 Years |
Eligibility |
Inclusion Criteria: 1. Child and parent are English speaking. 2. Child meets diagnostic criteria for Tourette's disorder or persistent (chronic) motor or vocal tic disorder according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders - 5th Edition. 3. Child scores >70 on a brief intelligence test 4. Child currently engages in at least one motor and/or vocal tic multiple times per day 5. Clinician rated tic severity score of > 3 (mildly ill or worse) 6. Child is unmedicated for tics or associated conditions or has been on stable psychotropic medication for at least 6 weeks with no changes or planned changes in dosage. 7. Family has daily access to a personal computer with internet access and software meeting TicHelper minimum system requirements. Exclusion Criteria: 1. A Yale-Global Tic Severity Scale (YGTSS) score > 30 2. Child scores < 70 on intelligence test 3. Child meets diagnostic criteria for substance abuse or dependence or conduct disorder (within past 3 months) according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders - 5th Edition. 4. Current or past non-drug treatment for tics that consisted of 4 or more sessions of habit reversal training or CBIT. 5. Child has lifetime diagnosis of mania or psychotic disorder 6. Child has any serious psychiatric or neurological condition not currently being managed, managed ineffectively, or requiring more immediate treatment other than that provided by the study. |
Country | Name | City | State |
---|---|---|---|
United States | Marquette University | Milwaukee | Wisconsin |
United States | University of Utah | Salt Lake City | Utah |
Lead Sponsor | Collaborator |
---|---|
University of Utah | Marquette University |
United States,
Piacentini J, Woods DW, Scahill L, Wilhelm S, Peterson AL, Chang S, Ginsburg GS, Deckersbach T, Dziura J, Levi-Pearl S, Walkup JT. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010 May 19;303(19):1929-37. doi: 10.1001/jama.2010.607. — View Citation
Woods DW, Piacentini JC, Scahill L, Peterson AL, Wilhelm S, Chang S, Deckersbach T, McGuire J, Specht M, Conelea CA, Rozenman M, Dzuria J, Liu H, Levi-Pearl S, Walkup JT. Behavior therapy for tics in children: acute and long-term effects on psychiatric and psychosocial functioning. J Child Neurol. 2011 Jul;26(7):858-65. doi: 10.1177/0883073810397046. Epub 2011 May 9. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in the Total Tic Severity Score on the Yale Global Tic Severity Scale (YGTSS) | Clinician interview to assess overall severity of tics | Baseline, Week 8 (post-treatment), Week 12 (1-month follow-up) | |
Secondary | Change in overall tic severity on the Clinician Global Impressions-Severity Scale | Measures clinician's impression of overall severity | Baseline, Week 8 (post-treatment), Week 12 (1-month follow-up) | |
Secondary | Clinician Global Impressions-Improvement Scale | Measures clinician's impression of improvement since starting treatment | Week 8 (post-treatment) | |
Secondary | Clinician Global Impressions- Improvement Scale | Measures clinician's impression of improvement since starting treatment | Week 12 (1-month follow-up) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02316145 -
Internet-based Coaching for Young Adults With Neuropsychiatric Disorders
|
N/A | |
Completed |
NCT00706589 -
Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder
|
Phase 3 | |
Completed |
NCT01416441 -
Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
|
Phase 3 | |
Completed |
NCT01727700 -
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
|
Phase 3 | |
Recruiting |
NCT06408662 -
Remote Delivery of a Mindfulness-based Intervention for Tics
|
N/A | |
Completed |
NCT01315327 -
Omega-3 Fatty Acids in Tourette's Disorder
|
N/A | |
Completed |
NCT01795105 -
ABF Tourette's Disorder Post Marketing Surveillance Study
|
||
Completed |
NCT01418339 -
Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
|
Phase 3 | |
Completed |
NCT01585207 -
Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder
|
Phase 1/Phase 2 | |
Completed |
NCT01727713 -
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
|
Phase 3 | |
Completed |
NCT03042507 -
Psychosocial Intervention for Young Children With Chronic Tics
|
N/A | |
Completed |
NCT03508245 -
Investigating Circadian Rhythms in Youth With Persistent Tic Disorders
|
N/A | |
Completed |
NCT02864589 -
Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder
|
N/A | |
Completed |
NCT01177774 -
Assessment of Children With Tic Onset in the Past 6 Months
|
||
Completed |
NCT01418352 -
Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)
|
Phase 3 | |
Recruiting |
NCT05499741 -
Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette's Disorder
|
N/A | |
Completed |
NCT03916055 -
Internet-delivered Behaviour Therapy for Children and Adolescents With Tourette's Disorder
|
N/A |